The GIANT Trial (ECOG-ACRIN EA2186) Methods Paper: A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment-Naïve Metastatic Pancreatic Cancer - Defining a New Treatment Option for Older Vulnerable Patients.
JOURNAL OF CLINICAL ONCOLOGY（2024）
关键词
Metastatic pancreatic cancer,Older patients,Vulnerable,Geriatric assessment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要